Suppr超能文献

一种由Cdc48和20S肽酶组成的替代性ATP驱动蛋白酶体组装的生物学和病理学意义

Biological and Pathological Implications of an Alternative ATP-Powered Proteasomal Assembly With Cdc48 and the 20S Peptidase.

作者信息

Esaki Masatoshi, Johjima-Murata Ai, Islam Md Tanvir, Ogura Teru

机构信息

Department of Molecular Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.

Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Saitama, Japan.

出版信息

Front Mol Biosci. 2018 Jun 8;5:56. doi: 10.3389/fmolb.2018.00056. eCollection 2018.

Abstract

The ATP-powered protein degradation machinery plays essential roles in maintaining protein homeostasis in all organisms. Robust proteolytic activities are typically sequestered within protein complexes to avoid the fatal removal of essential proteins. Because the openings of proteolytic chambers are narrow, substrate proteins must undergo unfolding. AAA superfamily proteins (ATPases associated with diverse cellular activities) are mostly located at these openings and regulate protein degradation appropriately. The 26S proteasome, comprising 20S peptidase and 19S regulatory particles, is the major ATP-powered protein degradation machinery in eukaryotes. The 19S particles are composed of six AAA proteins and 13 regulatory proteins, and bind to both ends of a barrel-shaped proteolytic chamber formed by the 20S peptidase. Several recent studies have reported that another AAA protein, Cdc48, can replace the 19S particles to form an alternative ATP-powered proteasomal complex, i.e., the Cdc48-20S proteasome. This review focuses on our current knowledge of this alternative proteasome and its possible linkage to amyotrophic lateral sclerosis.

摘要

由ATP供能的蛋白质降解机制在维持所有生物体的蛋白质稳态中起着至关重要的作用。强大的蛋白水解活性通常被隔离在蛋白质复合物中,以避免必需蛋白质被致命性地清除。由于蛋白水解腔的开口狭窄,底物蛋白必须进行解折叠。AAA超家族蛋白(与多种细胞活动相关的ATP酶)大多位于这些开口处,并适当地调节蛋白质降解。由20S蛋白酶体和19S调节颗粒组成的26S蛋白酶体是真核生物中主要的由ATP供能的蛋白质降解机制。19S颗粒由六个AAA蛋白和13个调节蛋白组成,并与由20S蛋白酶体形成的桶状蛋白水解腔的两端结合。最近的几项研究报告称,另一种AAA蛋白Cdc48可以替代19S颗粒,形成一种替代性的由ATP供能的蛋白酶体复合物,即Cdc48-20S蛋白酶体。本综述重点介绍了我们目前对这种替代性蛋白酶体的认识及其与肌萎缩侧索硬化症的可能联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b77a/6008533/e5685b9c6646/fmolb-05-00056-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验